| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.041 | 0.3 |